Kailera Therapeutics, Inc.

KLRA chart

Kailera Therapeutics, Inc. news

• Chinese Pharma Exports Near 200 Trillion Won, Outpacing South Korea

  조선일보 · Oct 26, 8:48 PM EDT

• Chinese Pharma, Biotech Near 200 Trillion Won Tech Exports

  조선일보 · Oct 26, 4:16 PM EDT

• Kailera Therapeutics, Inc. Estimates – NASDAQ:KLRA

  TradingView · Oct 25, 6:27 AM EDT

• Inhibikase Appoints Scott Wasserman to Board of Directors

  The Globe and Mail · Oct 21, 5:32 PM EDT

• We Think Kailera Therapeutics (NASDAQ:KLRA) Can Afford To Drive Business Growth

  Moomoo · Oct 21, 9:17 AM EDT

• Companies Like Kailera Therapeutics (NASDAQ:KLRA) Are In A Position To Invest In Growth

  Simply Wall Street · Oct 21, 7:37 AM EDT

• The 6 biggest crossover rounds in biopharma history

  BioSpace · Oct 21, 12:23 AM EDT

• Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors

  Yahoo Finance · Oct 20, 4:01 PM EDT

• Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

  Yahoo Finance · Oct 1, 6:45 AM EDT

• Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy

  fool.com · Sep 30, 7:30 PM EDT

• Kailera Therapeutics Completes Enrollment for Trial of Ribupatide to Treat Obesity

  Yahoo Finance · Sep 30, 7:44 AM EDT

• Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection

  Yahoo Finance · Sep 30, 7:00 AM EDT

Kailera Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-08-12
• 8-K8-K2026-08-12
• 10-Q10-Q2026-05-26
• 8-K8-K2026-05-26
• 8-K8-K2026-04-20
• S-1S-12026-03-27

About Kailera Therapeutics, Inc.

Ticker

KLRA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Waltham, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2096997

Frequently asked questions